Akutes Koronarsyndrom ohne ST-Streckenhebung

Willibald Hochholzer; Franz-Josef Neumann

doi:10.1055/s-0042-107115

DMW - Deutsche Medizinische Wochenschrift, Inhaltsverzeichnis

Dtsch Med Wochenschr 2016; 141(11): 782-785
DOI: 10.1055/s-0042-107115

Klinischer Fortschritt

Kardiologie

Akutes Koronarsyndrom ohne ST-Streckenhebung

Die neue Leitlinie der Europäischen Gesellschaft für KardiologieThe new 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Willibald Hochholzer

¹Klinik für Kardiologie und Angiologie II, Universitäts-Herzzentrum Freiburg ∙ Bad Krozingen

,

Franz-Josef Neumann

¹Klinik für Kardiologie und Angiologie II, Universitäts-Herzzentrum Freiburg ∙ Bad Krozingen

› Institutsangaben

Abstract

Zusammenfassung

Die Europäische Gesellschaft für Kardiologie hat 2015 aktualisierte Leitlinien zur Diagnostik und Therapie des akuten Koronarsyndroms ohne ST-Streckenhebung veröffentlicht. Der vorliegende Beitrag beschäftigt sich mit einigen der wichtigsten Neuerungen: der Einführung des 1-Stunden-Algorithmus zur Diagnostik mit hochsensitiven Troponin-Assays, der Präzisierung von Zeitvorgaben zur invasiven Strategie, neuen Empfehlungen zur Katheterintervention und periinterventionellen antithrombotische Therapie sowie neuen Aspekten der Sekundärprävention.

Abstract

In 2015 the European Society of Cardiology published a new version of the guidelines for the management of acute coronary syndromes without persistent ST-segment elevation. The current communication addresses some of the most important updates: introduction of the 1-hour diagnostic algorithm with high-sensitivity troponin assays, specified time lines for the invasive strategy, new recommendations for catheter intervention and peri-interventional antithrombotic therapy as well as new aspects of secondary prevention.

Schlüsselwörter

Akutes Koronarsyndrom - Nicht ST-Hebungsinfarkt - Leitlinie

Keywords

acute coronary syndrome - non ST-elevation myocardial infarction - guideline

Volltext

Referenzen

Literatur
1 Hamm CW, Bassand JP, Agewall S et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011; 32: 2999-3054
2 Jernberg T, Hasvold P, Henriksson M et al. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J 2015; 36: 1163-1170
3 Roffi M, Patrono C, Collet JP et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation. Eur Heart J 2016; 37: 267-315
4 Hochholzer W, Morrow DA, Giugliano RP. Novel biomarkers in cardiovascular disease: Update 2010. Am Heart J 2010; 160: 583-594
5 Reichlin T, Schindler C, Drexler B et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012; 172: 1211-1218
6 Rubini Gimenez M, Twerenbold R, Jaeger C et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med 2015; 128: 861-870
7 Neumann J, Sörensen N, Schwemer T et al. Accurate and rapid diagnosis of myocardial infarction using a high-sensitivity troponin I 1-hour algorithm. ESC Congress 2015; Hotline Session on August 30th 2015
8 Navarese EP, Gurbel PA, Andreotti F et al. Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis. Ann Intern Med 2013; 158: 261-270
9 Mehta SR, Granger CB, Boden WE et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009; 360: 2165-2175
10 Montalescot G, Bolognese L, Dudek D et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med 2013; 369: 999-1010
11 Bhatt DL, Stone GW, Mahaffey KW et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med 2013; 368: 1303-1313
12 Valgimigli M, Gagnor A, Calabro P et al. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet 2015; 385: 2465-2476
13 Palmerini T, Biondi-Zoccai G, Della Riva D et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 2012; 379: 1393-1402
14 Bangalore S, Toklu B, Amoroso N et al. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. BMJ 2013; 347: f6625
15 Mauri L, Kereiakes DJ, Yeh RW et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2014; 371: 2155-2166
16 Bonaca MP, Bhatt DL, Cohen M et al. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med 2015; 372: 1791-1800
17 Cannon CP, Blazing MA, Giugliano RP et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015; 372: 2387-2397